PNC Financial Services Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $157K | Hold |
1,325
| – | – | ﹤0.01% | 2636 |
|
|
2026
Q1 | $137K | Hold |
1,325
| – | – | ﹤0.01% | 2595 |
|
|
2025
Q4 | $139K | Buy |
1,325
+300
| +29% | +$30.2K | ﹤0.01% | 2574 |
|
|
2025
Q3 | $94.8K | Hold |
1,025
| – | – | ﹤0.01% | 2834 |
|
|
2025
Q2 | $81.9K | Hold |
1,025
| – | – | ﹤0.01% | 2840 |
|
|
2025
Q1 | $88.8K | Hold |
1,025
| – | – | ﹤0.01% | 2746 |
|
|
2024
Q4 | $84.7K | Hold |
1,025
| – | – | ﹤0.01% | 2782 |
|
|
2024
Q3 | $89.1K | Hold |
1,025
| – | – | ﹤0.01% | 2734 |
|
|
2024
Q2 | $84.3K | Hold |
1,025
| – | – | ﹤0.01% | 2727 |
|
|
2024
Q1 | $82.2K | Buy |
1,025
+525
| +105% | +$40.7K | ﹤0.01% | 2726 |
|
|
2023
Q4 | $38K | Hold |
500
| – | – | ﹤0.01% | 3103 |
|
|
2023
Q3 | $36.2K | Hold |
500
| – | – | ﹤0.01% | 3118 |
|
|
2023
Q2 | $37.8K | Hold |
500
| – | – | ﹤0.01% | 3218 |
|
|
2023
Q1 | $38K | Hold |
500
| – | – | ﹤0.01% | 3134 |
|
|
2022
Q4 | $39.3K | Hold |
500
| – | – | ﹤0.01% | 3123 |
|
|
2022
Q3 | $36K | Hold |
500
| – | – | ﹤0.01% | 3159 |
|
|
2022
Q2 | $37K | Hold |
500
| – | – | ﹤0.01% | 3172 |
|
|
2022
Q1 | $40K | Hold |
500
| – | – | ﹤0.01% | 3230 |
|
|
2021
Q4 | $41K | Hold |
500
| – | – | ﹤0.01% | 3221 |
|
|
2021
Q3 | $39K | Buy |
+500
| New | +$40.3K | ﹤0.01% | 3210 |
|
|
2018
Q3 | – | Sell |
-24
| Closed | -$2K | – | 4210 |
|
|
2018
Q2 | $2K | Hold |
24
| – | – | ﹤0.01% | 3993 |
|
|
2018
Q1 | $2K | Hold |
24
| – | – | ﹤0.01% | 4050 |
|
|
2017
Q4 | $2K | Sell |
24
-17
| -41% | -$1.09K | ﹤0.01% | 4014 |
|
|
2017
Q3 | $3K | Hold |
41
| – | – | ﹤0.01% | 3957 |
|
|
2017
Q2 | $3K | Sell |
41
-657
| -94% | -$39.4K | ﹤0.01% | 3933 |
|
|
2017
Q1 | $41K | Buy |
698
+571
| +450% | +$33.4K | ﹤0.01% | 2977 |
|
|
2016
Q4 | $7K | Hold |
127
| – | – | ﹤0.01% | 3595 |
|
|
2016
Q3 | $8K | Buy |
127
+59
| +87% | +$3.86K | ﹤0.01% | 3548 |
|
|
2016
Q2 | $4K | Sell |
68
-170
| -71% | -$10.7K | ﹤0.01% | 3939 |
|
|
2016
Q1 | $14K | Hold |
238
| – | – | ﹤0.01% | 3427 |
|
|
2015
Q4 | $17K | Buy |
238
+12
| +5% | +$851 | ﹤0.01% | 3374 |
|
|
2015
Q3 | $15K | Sell |
226
-363
| -62% | -$28.2K | ﹤0.01% | 3510 |
|
|
2015
Q2 | $46K | Buy |
589
+82
| +16% | +$6.38K | ﹤0.01% | 3063 |
|
|
2015
Q1 | $39K | Buy |
507
+141
| +39% | +$10.4K | ﹤0.01% | 3173 |
|
|
2014
Q4 | $24K | Hold |
366
| – | – | ﹤0.01% | 3082 |
|
|
2014
Q3 | $23K | Hold |
366
| – | – | ﹤0.01% | 3010 |
|
|
2014
Q2 | $22K | Buy |
+366
| New | +$21.2K | ﹤0.01% | 2898 |
|
|
2013
Q4 | – | Sell |
-264
| Closed | -$12K | – | 3515 |
|
|
2013
Q3 | $12K | Hold |
264
| – | – | ﹤0.01% | 3184 |
|
|
2013
Q2 | $12K | Buy |
+264
| New | +$11K | ﹤0.01% | 3040 |
|
Other funds holding PJP
JGCM
DBIA
TC
IFWM
PNC Financial Services Group's PJP Position: Q2 2026 in Review
PNC Financial Services Group held its Invesco Pharmaceuticals ETF (PJP) position steady in Q2 2026 at 1,325 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #2636.
PNC Financial Services Group first reported a position in PJP in Q2 2013 and has held it in 39 quarters since. 68 funds tracked by Wall St. Rank hold PJP as of Q2 2026.
- PNC Financial Services Group held 1,325 shares of Invesco Pharmaceuticals ETF worth $157K as of Q2 2026.
- PNC Financial Services Group left its Invesco Pharmaceuticals ETF share count unchanged in Q2 2026.
- Invesco Pharmaceuticals ETF made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2636 holding.
- PNC Financial Services Group first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 39 quarters since.
- 68 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.